Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Has anyone heard from Keith, our VP of sales. He tweeted 11 times in January and has gone silent ever since. I sent him a couple of emails and he has not responded.
I’m with you JGD. I added to my position again today. I feel badly for the shortsighted investors who will be despondent once all the other great news starts flowing in and the share price raises at a rate that they won’t be able to catch.
Here is what Kelly emailed me when I asked when Dr. Richard Staelin is going to do another chairman’s letter to update investors on the latest news:
“Thank you for your note. I will speak with Rick about another update from him soon. We prefer to do less updates with more substantial news.”
Kelly has to be very careful with the information she shares. She did not provide any information on investor 1. I don’t think any of us truly know the impact that COVID-19 has had on the company. Everyone has their own investor tolerance level. I choose patience and optimism. And this is coming from someone who has been a shareholder for almost 15 years.
Kelly and Keith will share some information with me from time to time because I treat them with kindness and respect.
Please see below Kelly’s response to my email:
The party 2/3 deal is apparently still moving forward. They have offered up Covid as a reason for the delays- unable to get logos heat sealed from China..blah..blah…they tell us they are getting it done and we certainly hope that is true but we have not been sitting around waiting on it. In fact, we have made great strides with a different partner for US retail distribution. Samples for the retail buyers are currently being rapidly produced. This partner will be bringing the product to market using their well-known brand name and needs the samples to appear the way they will branded as “X” for the buyers. We expect to be finalizing a contract this month as we are collectively shooting for a 1st quarter 2021 retail on shelf launch.
I know nothing ever happens fast enough for shareholders (including employee shareholders!) but we are moving at a lightening speed considering all the unknowns in the retail environment and the inability to have in person meetings.
Keep the faith, good things come to those who persevere.
My response from Kelly regarding party 2 & 3 finalizing a deal.
Here is some of the email she sent me:
The party 2/3 deal is apparently still moving forward. They have offered up Covid as a reason for the delays- unable to get logos heat sealed from China..blah..blah…they tell us they are getting it done and we certainly hope that is true but we have not been sitting around waiting on it. In fact, we have made great strides with a different partner for US retail distribution. Samples for the retail buyers are currently being rapidly produced. This partner will be bringing the product to market using their well-known brand name and needs the samples to appear the way they will branded as “X” for the buyers. We expect to be finalizing a contract this month as we are collectively shooting for a 1st quarter 2021 retail on shelf launch.
I know nothing ever happens fast enough for shareholders (including employee shareholders!) but we are moving at a lightening speed considering all the unknowns in the retail environment and the inability to have in person meetings.
Keep the faith, good things come to those who persevere.
The email reply from Kelly was from May 11th.
Any information from the Company that is material in nature will be in the form of a press release. We aren’t going to share anything material via an Investor Update. The office staff is still primarily working remotely- which is also the case with most of the other entities we have been in contact with over the last months. Covid-19 has most definitely slowed everything down, and we decided not to put out an Investor Update detailing how it has affected us as anyone who is in business should be aware of the effects of Covid-19. At this point, we feel an Investor Update would be viewed as a litany of excuses…and we aren’t making excuses. We are working.
We have a good deal in place that involves three parties- our part is complete. We need to confirm that party 2 and 3 have a signed agreement in place. We were told March 13th via an email from party 2 that the deal is “finalized” but later discovered they did not/do not have a signed agreement, and until they do, the news will not be released and parties 2 and 3 will not be named. Our team isn’t going to take the risk of announcing this deal until we confirm all parties have signed on the dotted lines. We will release the PR when we have absolute certainty that all relevant contracts are signed.
We appreciate your loyalty. You can phone me directly with any questions or concerns you have about your investment. My direct line is 301 476 4376.
Kelly
Here is the response from Kelly to my email about an investor update:
Any information from the Company that is material in nature will be in the form of a press release. We aren’t going to share anything material via an Investor Update. The office staff is still primarily working remotely- which is also the case with most of the other entities we have been in contact with over the last months. Covid-19 has most definitely slowed everything down, and we decided not to put out an Investor Update detailing how it has affected us as anyone who is in business should be aware of the effects of Covid-19. At this point, we feel an Investor Update would be viewed as a litany of excuses…and we aren’t making excuses. We are working.
We have a good deal in place that involves three parties- our part is complete. We need to confirm that party 2 and 3 have a signed agreement in place. We were told March 13th via an email from party 2 that the deal is “finalized” but later discovered they did not/do not have a signed agreement, and until they do, the news will not be released and parties 2 and 3 will not be named. Our team isn’t going to take the risk of announcing this deal until we confirm all parties have signed on the dotted lines. We will release the PR when we have absolute certainty that all relevant contracts are signed.
We appreciate your loyalty. You can phone me directly with any questions or concerns you have about your investment. My direct line is 301 476 4376.
Kelly
Message from Keith. The following is a message from Keith. Kelly asked him to respond to my email about marketing strategy and why OEM over retail stores. Here is the email he sent me.
Thanks for the response as well as being a shareholder. Let me address these questions for you to give some clarity that comes from a 20 year career in the OTC space. I have relationships with every major retailer and have a clear understanding what type of products they are looking for to bring in store. Let me take this in pieces.
1. Why OEM first? Retailers on a national level reset their store once a year. In the pain category that happens in the fall annually. Retailers first question is always, "what are you going to spend to get this to sell" if the launch would be nationally, that would take on the order of 3-5mm dollar campaign. The OEM strategy allows us to work with partners who have existing retail presence. The ones we are in talks with have 40k plus retailer store distribution. For us to do that ourselves, it would take 5-7 years to get into that many stores. Retailers also would charge us 3-5 in just placement fees in addition to the marketing money. The OEM side allows us to fast forward that process, maintain 60% plus margins and have the marketing cost handled by the partner.
2. If you place a brand with out recognition into a large retailer it will fail. This process has to come at the same time, just because its on the shelf in a big box store means nothing. WM more than others.
3. The other side of retail is as basic as logistics. These retailers require large infrastructure to deliver product, this is better done with a partner who has this in place. The other side of retail is branding, packaging and customer acceptance. With partners we can drive sales with their existing customers who also are looking for pain products.
The partners we are finalizing things with will give rapid exposure to 50k plus retail outlets. 60% of doctors offices. 70% of all PT and chiros. They also bring over 250 reps both inside and outside to sell the product. Actipatch needs some consumer education to maximize sales. Reps seeks recommendations from doctors who tell patients where to get it in retailers. See the Senekot program, this I built from the ground up.
So in summation, the margins are better with OEM, volume is also higher. It drives brand exposure and customer awareness. I understand things never happen quick enough. If you don't build things correctly in retail, no matter how good the product you are destined to fail. We are here to win, we have made tremendous strides in restarting discussions with great partners who are right at a finish line. Thanks for the message.
Chris van Heerden is revered in South Africa so I think Erin thinks that would be a great fit. I passed the ball over to my daughter, who is an actress and influencer. She will explain the opportunity that exists because Chris is well connected in the fighting world (including being friends with Connor McGregor)
It’s just nice to see that the company is open to athletes promoting the products. Maybe they are in full fledged revenue mode.
Influencers welcome. I just received an email from Erin Sanders (Sales Manager for BioElectronics) She responded to an email I sent regarding a boxing influencer named Chris van Heerden (originally from South Africa and now living in Los Angeles) He is the former IBO welterweight champion and (my daughter’s boyfriend) He is fighting on April 25 in Las Vegas in an elimination -fight with the winner going on for a shot at the title. He recently tried the Actipatch to give him some relief from some shoulder pain he was experiencing. He was amazed
at how great it worked to take his pain away. He said that this would be perfect for boxers because they are constantly being drug tested. He was so impressed that he became an investor.
Here is Erins email to me:
Hello Jeff
My name is Erin and I am in charge of international sales for ActiPatch. We are currently getting a distributor in place for South Africa. As I see you would like to influence other boxers, I am all for that, however, currently, South Africa can’t legally get Actipatch until it is registered and sold on store shelves. Could we keep in touch, as this process is completed in order to move forward?
Please keep in touch with me at any time and I will add you to my contacts.
Erin Sanders
Sales Manager – Actipatch Products
BioElectronics Corp.
1 301-363-2094 USA
Whatsapp 1-240-888-9229
SKYPE erin.sanders.bioelectronics
I asked Paul when we can expect our next communication. Here was his response:
We've been issuing them around the first and 16th of the month. We'll see what new management wants to do.
Paul Knopick
There are 18 reviews on Walmart.com. ALL 18 give the Actipatch 5 out of 5 stars. All investors should buy online at Walmart. Keith is meeting again with them in August. Let's all do our part to prove that all the products should be on the shelves come January.
Andy just got back to me. He said, and I'm quoting: "The interview should air tomorrow on Up Tick site."
I just fired off an email to Andy asking him to clarify if he meant Keith is going to be on Uptick Radio this morning. I will keep you posted.
Here is Andy's actual quote (grammatical error and all):
Keith is being interviewed by UpTick Radio in the mornings which will answer
most of your questions.
Here is the email I sent to Andy that he responded to by letting me know about Keith and Uptick tomorrow:
Hello Andy,
Please accept my heart felt congratulations on getting the Recovery Rx
acceptance from the FDA. It is an incredible achievement and you deserve a
lot of credit. I have been turning the pages on the BIEL story for more than
12 years now and I am excited for a happy ending to this amazing book.
I know I speak for all investors when I say we are loving the regular
updates.
If I could be so bold as to request what most investors are asking for in
the next update:
What is the CVS plan? Will the product be going into the 9000 stores?
What happened with Bayer and the Smart Insole?
What is the latest on the VA?
Have you or Keith considered sending free samples to high profile athletes
to try and report for free on their social media platforms?
Maybe it's time to pay a visit to Dr. Oz. and inform customers they can get
the ActiPatch online at Walmart. That would demonstrate to Walmart why the
product should be in the stores.
If you're familiar with blitz scaling, I think the time is now to get the
story out in a big way. A PPS of .001 is hard to swallow given the
disruptive potential of the products. For a cynical and exhausted
shareholder base it appears as they are only interested in the ability for
the company to generate revenue.
Thanks Andy. You should be proud of what you have accomplished. Now it's
time to take it to the next level and reward the thousands of loyal
investors who put their faith in you.
All the best,
I received an email from Andy today. He said Keith is being interviewed on Uptick Radio tomorrow and will answer most of the questions I asked.
I agree Toohot. I to consider myself an investor. I bought my first shares in 2007 and have been adding shares ever since.
Yes, there have been many missteps along the way, however, the effectiveness of the products is undeniable. BIEL can be a disruptor in the pain management space. Day traders are very short sighted when it comes to BIEL. There are not too many companies where you can own millions of shares of the company that have FDA approved devices and are in revenue driving mode. So, day trade if you like and make a few dollars, or hold tight and retire rich. I prefer the latter.
Regarding where to put the Actipatch for tinnitus, my son put his ear in the center of the loop and held it into place with a toque.
As a 12 year investor and frequent user of the Actipatch, let me present another testimonial. A few months ago I posted the pain relief that my 23 year old son got with his tinnitus (which is now gone). This week my wife had very bad neck pain that would not go away, despite my feeble attempts at massage. I placed the Actipatch over the painful area and had her put a light scarf on to hold it into place. By morning she reported that the pain was 70% gone and she had more mobility. I know it is a slow process, however, as many medical professionals are coming to understand; electroceuticals is the future of pain management. One thing I am convinced of; the big fish are very aware of this minnow. GLTA
I am an ethical investor. I don't BS or play games. Paul from
E & E Communications just replied to my email and said that Andrew will be posting a letter to shareholders tomorrow.
I just received an email from Paul Knopick. He said the president will be posting a letter tomorrow.
When I first invested in BIEL in 2007, I e-mailed Health Canada (Canada's version of the FDA) and asked them how long it took them to approve the Actipatch.
The answer was "less than 14 days". I think the Company missed an opportunity to drive sales in Canada and use it as a huge test market. However, I remain confident of a positive outcome from the FDA followed by a Bayer partnership. Let's make no mistake about it, it will take one of the big boys to bring this company to the next level.
Tomorrow is day 82 FDA holding 510(K)......we're getting closer.
20/20.....story on opioids on Friday.
60 Minutes.....story on opioids on Sunday.
It seems that a day does not pass without heartbreaking stories on the opioid addiction the world is facing. If only there was a product that really works to reduce pain with zero side effects.
Hello Team BIEL. Monday will be day 81 since the 510(k) filing with the FDA. While it is very curious why it is taking so long (they are very familiar with the Company/ opioid crisis), I think approval is eminent. To go this long without asking BIEL for more follow up questions is very promising. We're getting closer. Hang in there everyone.
Bayer need BioElectronics. Please see the article on how research suggests there is no benefit for daily use of aspirin in healthy and older people. The board of directors will be demanding additional revenue streams as they lose market share with their staple product.
https://www.ctvnews.ca/health/research-suggests-no-benefit-for-daily-use-of-aspirin-in-healthy-older-people-1.4096801
I've been patiently waiting since 2007. I am confident my patience is about to be rewarded.
GLTA
Add another body part to the list. My son has been experiencing great pain in his ears. (He went to the hospital 4 times for the pain) they said there is no cure. The Doctor said it is tinnitus. I bought two Actipatches and had him wear them with the loops over his ears and tied a bandanna to hold them in place. For the first time in days he got a good nights sleep and in the morning the pain had subsided greatly.
I'm telling you........ this is going to be huge!!
Art, I am with you brother. I am a long time very experienced successful investor. Mostly blue chip and emerging small cap companies. BIEL is the only penny stock I own. I don't even remember how I stumbled upon it. But, I truly understand the enormous growth potential with this company. This is why I have refused to sell any of my shares over the past 11 years.
I am not a daytrader, I am an investor.
Greeting to my fellow BIELevers. I don't post too often but enjoy reading the comments. I'm from just outside of Burlington Ontario Canada. I've held all my shares (7,800,000) for over 11 years now. My confidence has never wavered. I have used the Actipatch many times over the years with great results.
I really believe BIEL can be a disruptor in the pharmaceutical and medical industry. 2018 will be the year the share price gets out of sub penny land. If I can go over 3000 trading days without trading one share, you can too. Start looking at the big picture.
All the best!
President Whelan emailed me on Thursday and said he will be coming out with a letter in the next few days. He ended the email with: "Things are good." Hopefully we will hear some positive news this week.
Keep the faith everyone. For the health and well-being of all Americans (and Canadians) BIEL products need to be in every medicine cabinet.
Good luck to all.
I just received an e-mail from Andrew and he said he will "get a letter out in the next few days".
He ended it by saying "Things are good".
Be patient my friends..........it's coming.
BIEL is very quickly making an impact with customers on Amazon. For example: BEST SELLER RANK
Arthritis products: Actipatch went from 37th rank to now 25
Alternative Pain Relief: Actipatch went from 64th rank to now 51
Treatments: Actipatch went from 122nd rank to now 95
(You have to click on the "word in bold" and scroll through the products) the best seller rank has not been updated.
This is all within a very short time. I have been an investor for 10 years. I have never wavered in my
belief and support for the company. Word is getting out about the benefits of these great products.
It is just a matter of time before this explodes. I have been patient for over ten years. I encourage
every BIEL investor to buy and hold. Your patience will be rewarded greatly .
This is just IMOP.
Best of luck to all the faithful long term investors.
http://www.stitcher.com/podcast/uptick-newswire/uptick-network/e/andrew-whelan-ceo-of-bioelectronics-discusses-their-new-pain-48255054
Wait for the last statement from Andrew.
BIEL absolutely has the potential to be a disruptor in the pharmaceutical industry.
The following is the response from Andrew to some questions I asked him. His brother Ed (head of investor relations) is recovering in the hospital from surgery.
1. Has the FDA given any indication as to when the other products will
be approved for over the counter use? Within 2017?
The next FDA clearance should be for a broader indication of use for
musculoskeletal pain including the back. We need to get the Oxford
University back pain study completed and submit to the FDA. Market clearance
should be around mid-2017.
2. Is BioElectronics Inc. in consultation with Walgreens or Walmart?
Not yet, we are trying to get a sales and marketing partner with adequate
financial and managerial resources to provide worldwide market distribution
coverage,
3. You indicated that the company would not consider a reverse split
until after it becomes profitable. How will we, as investors, know when the
profitability threshold has been met?
Reversing the stock without adequate market support from a significant
broker/dealer can be a disaster. We provide quarterly financial statements
that are posted on our website and the OTCMarkets website.
Andy
Andrew J. Whelan, President
BioElectronics Corporation
4539 Metropolitan Court
Frederick, MD 21704
(301) 874-4890 , Extension #107
Cell: (301)-943-0914 Fax: (301) 874-6935
Skype: Andy.Whelan.BioElectronics
Web: www.bielcorp.com
http://actipatch.com/testimonials/